Developing safer dental materials that can help repair teeth
High-performance BPA-free dental restoration composites with remineralization capabilities
['FUNDING_OTHER'] · CALLENTIS CONSULTING GROUP LLC · NIH-11007708
This study is working on new dental materials that are safer and better for your teeth, without harmful chemicals, to help make your dental work last longer and improve your overall oral health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CALLENTIS CONSULTING GROUP LLC (nih funded) |
| Locations | 1 site (AUSTIN, UNITED STATES) |
| Trial ID | NIH-11007708 on ClinicalTrials.gov |
What this research studies
This research focuses on creating new dental restoration materials that do not contain bisphenol A (BPA), which can leach harmful substances into the body. The approach involves inventing novel urethane-based monomers that, when combined with acidic comonomers, achieve high performance and durability in dental applications. The goal is to produce materials that not only perform better than current options but also enhance the remineralization of dental enamel, potentially improving oral health outcomes for patients. By using advanced photocuring techniques, these new materials aim to minimize shrinkage and stress during the curing process, leading to longer-lasting dental restorations.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who require dental restorations and are concerned about the health impacts of traditional materials.
Not a fit: Patients who do not require dental restorations or those who are not concerned about the materials used in their dental care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective dental restoration materials that improve patient health and comfort.
How similar studies have performed: While there have been efforts to develop BPA-free dental materials, this research aims to introduce a novel approach that has not been extensively tested in the market.
Where this research is happening
AUSTIN, UNITED STATES
- CALLENTIS CONSULTING GROUP LLC — AUSTIN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STANSBURY, JEFFREY W. — CALLENTIS CONSULTING GROUP LLC
- Study coordinator: STANSBURY, JEFFREY W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cardiac Diseases